S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10

Tekcapital (TEK) Share Forecast, Price & News

GBX 26.50
0.00 (0.00%)
(As of 05/27/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
950,556 shs
Average Volume
996,236 shs
Market Capitalization
£37.52 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive TEK News and Ratings via Email

Sign-up to receive the latest news and ratings for Tekcapital and its competitors with MarketBeat's FREE daily newsletter.

Tekcapital logo

About Tekcapital

Tekcapital plc, together with its subsidiaries, provides a range of technology transfer services to universities and corporations in the United Kingdom and the United States. The company operates in two segment, Professional Services, and Licensing and Investment Activities. It engages in the provision of recruitment services; and reports and services to locate and transfer technologies to customers, as well as offers R&D tax relief credits, management services, and intellectual property services to third party customers. The company involves in acquiring licenses for technologies, and portfolio company investment, development, and commercialization. Tekcapital plc was incorporated in 2014 and is headquartered in London, the United Kingdom.


See More Headlines

Industry, Sector and Symbol

Business Software & Services
Year Founded

Sales & Book Value

Annual Sales
£29.05 million
Cash Flow
GBX 2.55 per share
Book Value
GBX 48.10 per share


Pretax Margin




Free Float
Market Cap
£37.52 million
Not Optionable


Overall MarketRank

1.31 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Tekcapital (LON:TEK) Frequently Asked Questions

Who are Tekcapital's key executives?
Tekcapital's management team includes the following people:
  • Dr. Clifford Mark Gross MBA, Ph.D., Exec. Chairman, CEO & Member of Science Advisory Board (Age 64, Pay $368.99k)
  • Mr. Alexander Maxwell Hamilton Inglis MBA, Co-Founder, Gen. Counsel and Company Sec.
  • Mr. Konrad Dabrowski, Chief Financial Officer (Age 39)
  • Mr. Selwyn Lloyd MBA, Chief Information Officer
  • Mr. Michael S. Rosen, Managing Director of Academic & Entrepreneurship Training
  • Dr. Jay Shah, Chief Medical Officer of MicroSalt
  • Mr. Glen Gardner, Pres of Vortechs Group
  • Victor Hugo Manzanilla, Chief Exec. Officer of MicroSalt
What other stocks do shareholders of Tekcapital own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tekcapital investors own include Augean (AUG), Barclays (BARC), AzurRx BioPharma (AZRX), AstraZeneca (AZN), Avacta Group (AVCT), Athabasca Oil (ATHOF), ARC Resources (ARX), American Tower (AMT), Agrium (AGU) and ADLER Real Estate (ADL).

What is Tekcapital's stock symbol?

Tekcapital trades on the London Stock Exchange (LON) under the ticker symbol "TEK."

How do I buy shares of Tekcapital?

Shares of TEK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Tekcapital's stock price today?

One share of TEK stock can currently be purchased for approximately GBX 26.50.

How much money does Tekcapital make?

Tekcapital has a market capitalization of £37.52 million and generates £29.05 million in revenue each year.

How many employees does Tekcapital have?

Tekcapital employs 6 workers across the globe.

What is Tekcapital's official website?

The official website for Tekcapital is tekcapital.com.

How can I contact Tekcapital?

Tekcapital's mailing address is Oxford Centre For Innovation, New Road, OXFORD, OX1 1BY, United Kingdom. The company can be reached via phone at +44-1865-261445.

This page was last updated on 5/28/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.